Halevas, E.; Kokotidou, C.; Zaimai, E.; Moschona, A.; Lialiaris, E.; Mitraki, A.; Lialiaris, T.; Pantazaki, A.
Evaluation of the Hemocompatibility and Anticancer Potential of Poly(ε-Caprolactone) and Poly(3-Hydroxybutyrate) Microcarriers with Encapsulated Chrysin. Pharmaceutics 2021, 13, 109.
https://doi.org/10.3390/pharmaceutics13010109
AMA Style
Halevas E, Kokotidou C, Zaimai E, Moschona A, Lialiaris E, Mitraki A, Lialiaris T, Pantazaki A.
Evaluation of the Hemocompatibility and Anticancer Potential of Poly(ε-Caprolactone) and Poly(3-Hydroxybutyrate) Microcarriers with Encapsulated Chrysin. Pharmaceutics. 2021; 13(1):109.
https://doi.org/10.3390/pharmaceutics13010109
Chicago/Turabian Style
Halevas, Eleftherios, Chrysoula Kokotidou, Elda Zaimai, Alexandra Moschona, Efstratios Lialiaris, Anna Mitraki, Theodore Lialiaris, and Anastasia Pantazaki.
2021. "Evaluation of the Hemocompatibility and Anticancer Potential of Poly(ε-Caprolactone) and Poly(3-Hydroxybutyrate) Microcarriers with Encapsulated Chrysin" Pharmaceutics 13, no. 1: 109.
https://doi.org/10.3390/pharmaceutics13010109
APA Style
Halevas, E., Kokotidou, C., Zaimai, E., Moschona, A., Lialiaris, E., Mitraki, A., Lialiaris, T., & Pantazaki, A.
(2021). Evaluation of the Hemocompatibility and Anticancer Potential of Poly(ε-Caprolactone) and Poly(3-Hydroxybutyrate) Microcarriers with Encapsulated Chrysin. Pharmaceutics, 13(1), 109.
https://doi.org/10.3390/pharmaceutics13010109